key: cord-0745319-qgrn4lsm
authors: Marshall, Shoko; Ishikawa, Motonao; Tanaka, Hiroaki; Sakura, Hiroshi; Uchigata, Yasuko
title: Universal testing for SARS-CoV-2 infection on admission among hospitalized emergency patients: A survey report from a single facility in Tokyo
date: 2021-09-20
journal: Infect Dis Health
DOI: 10.1016/j.idh.2021.09.002
sha: 1039c76662545f7e1445d7ac1a4d3bd36ef72ac4
doc_id: 745319
cord_uid: qgrn4lsm

We aimed to determine the prevalence of SARS-CoV-2 infection among urgently hospitalized patients between April 17 and September 30, 2020. The prevalence of SARS-CoV-2 infections on admission among hospitalized emergency patients was 6.2% (asymptomatic 0.25%, symptomatic 31%). Universal testing of asymptomatic patients in Tokyo using SARS-CoV-2 RT-PCR tests revealed a low prevalence of infection; therefore screening patients for the presence of COVID-19 symptoms on admission and testing those with symptoms should be given higher priority than universal PCR testing.

The coronavirus disease 2019 (COVID-19) pandemic is a global public health 1 emergency. Nosocomial infections are a risk. Approximately 40-45% of severe acute 2 respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are asymptomatic. 1 3 Individuals with asymptomatic infection can transmit SARS-CoV-2 to others for 14 4 days or longer. 1 5 Our 450-bed university hospital, located in north-eastern Tokyo, is a core hospital in the 6 area and provides advanced medical care. There was a total of 13,535 inpatients in all 7 departments in 2019. On April 17, 2020, five staff members were confirmed to have 8 SARS-CoV-2 infection. This led to restrictions being imposed on inpatient and 9 outpatient services. In order to prevent nosocomial infections, real-time reverse 10 transcription polymerase chain reaction (RT-PCR) testing was subsequently made 11 mandatory for all hospitalized patients. All patients undergoing emergency 12 hospitalizations were tested for SARS-CoV-2 on admission, and patients were isolated 13 until a negative test result was confirmed. 14 Tokyo, with a population of approximately 14 million, has the highest incidence of 15 COVID-19 in Japan, with 25,732 confirmed cases being reported between January 14 16 and September 30, 2020 ( Figure 1 ). In Japan, the value of PCR testing of all 17 hospitalized patients, including those who are asymptomatic, is unclear. This issue is 18 especially important for emergency admissions because testing cannot be done in 19 advance. 20

We aimed to determine the prevalence of SARS-CoV-2 infection among urgently 21 hospitalized patients. Patients with signs consistent with SARS-CoV-2, including fever, 22 respiratory symptoms, hypoxemia, or X-ray evidence of lower respiratory tract disease 23 were classified as symptomatic. Patients in the neonatal intensive care unit were 24 excluded from the analysis. Our hospital performs SARS-CoV-2 RT-PCR tests using 25 The prevalence of SARS-CoV-2 infections on admission among hospitalized 55 emergency patients was 6.2% (asymptomatic 0.25%, symptomatic 31%). Furthermore, 56 the incidence of new cases of Covid-19 in Tokyo between April to September 2020 was 57 25,206. 2 The population of Tokyo over the same period was 14,082,072, 3 which makes 58 the detection rate of 0.18%. Therefore, the detection rate among asymptomatic patients 59 in our study was similar to the detection rate in the general Tokyo population. In Tokyo, 60 two previous studies, using universal PCR testing, showed an asymptomatic SARS-61

CoV-2 prevalence of 0.03% (2 out of 6,224) 4 

Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review

Universal PCR screening for coronavirus disease 2019 in asymptomatic patients on admission

Screening for Asymptomatic Patients: A Report From Tokyo, Japan

Number of positive cases of Severe acute respiratory syndrome coronavirus-2 in Tokyo